BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2691383)

  • 1. ras p21 oncoprotein is autoregulated and acts as a potential mediator of insulin action or the H-ras1 promoter.
    Pintzas A; Spandidos DA
    Gene Anal Tech; 1989; 6(6):125-30. PubMed ID: 2691383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential potency and trans-activation of normal and mutant T24 human H-ras1 gene promoters.
    Spandidos DA; Pintzas A
    FEBS Lett; 1988 May; 232(2):269-74. PubMed ID: 3288499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol ester-responsive H-ras1 gene promoter contains multiple TPA-inducible/AP-1-binding consensus sequence elements.
    Spandidos DA; Nichols RA; Wilkie NM; Pintzas A
    FEBS Lett; 1988 Nov; 240(1-2):191-5. PubMed ID: 3056746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus long terminal repeat responds to transformation by the mutant T24 H-ras1 oncogene and it contains multiple AP-1 binding TPA-inducible consensus sequence elements.
    Spandidos DA; Yiagnisis M; Pintzas A
    Anticancer Res; 1989; 9(2):383-6. PubMed ID: 2665635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immortalization by truncated myc or ras genes and synergism between myc and ras genes in cell transformation.
    Spandidos DA; Lang JC
    Anticancer Res; 1989; 9(4):1149-52. PubMed ID: 2683993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The normal human H-ras1 gene can act as an onco-suppressor.
    Spandidos A; Wilkie NM
    Br J Cancer Suppl; 1988 Dec; 9():67-71. PubMed ID: 3076068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the normal H-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes.
    Spandidos DA; Frame M; Wilkie NM
    Anticancer Res; 1990; 10(6):1543-54. PubMed ID: 2285227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of the human immunodeficiency virus long terminal repeat sequences by cis-platin.
    Spandidos DA; Zoumpourlis V; Kotsinas A; Maurer HR; Patsilinacos P
    Genet Anal Tech Appl; 1990 Sep; 7(5):138-41. PubMed ID: 1965411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional enhancer activity in the variable tandem repeat DNA sequence downstream of the human Ha-ras 1 gene.
    Spandidos DA; Holmes L
    FEBS Lett; 1987 Jun; 218(1):41-6. PubMed ID: 3297784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sp1 specific binding sites within the human H-ras promoter: potential role of the 6 bp deletion sequence in the T24 H-ras1 gene.
    Pintzas A; Spandidos DA
    Anticancer Res; 1991; 11(6):2067-70. PubMed ID: 1776841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human T24 Ha-ras1 oncogene: a study of the effects of overexpression of the mutated ras gene product in rodent cells.
    Spandidos DA
    Anticancer Res; 1986; 6(2):259-62. PubMed ID: 3486626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat.
    Vacca A; Screpanti I; Maroder M; Petrangeli E; Frati L; Gulino A
    Mol Endocrinol; 1989 Oct; 3(10):1659-65. PubMed ID: 2558300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotor and enhancer like activity at the 5'-end of normal and T24 Ha-ras1 genes.
    Spandidos DA; Riggio M
    FEBS Lett; 1986 Jul; 203(2):169-74. PubMed ID: 3460819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene.
    Hurlin PJ; Maher VM; McCormick JJ
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):187-91. PubMed ID: 2643097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cis-platin responsive sequences in the human c-myc promoter.
    Spandidos DA; Zoumpourlis V; Lang JC
    Anticancer Res; 1991; 11(3):1339-42. PubMed ID: 1888169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A repetitive sequence element 3' of the human c-Ha-ras1 gene has enhancer activity.
    Cohen JB; Walter MV; Levinson AD
    J Cell Physiol Suppl; 1987; Suppl 5():75-81. PubMed ID: 3316256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterologous expression and characterization of the human R-ras gene product.
    Lowe DG; Goeddel DV
    Mol Cell Biol; 1987 Aug; 7(8):2845-56. PubMed ID: 3313005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of PI 3-kinase and RAS blocks IGF-I and insulin-induced uncoupling protein 1 gene expression in brown adipocytes.
    Teruel T; Valverde AM; Navarro P; Benito M; Lorenzo M
    J Cell Physiol; 1998 Jul; 176(1):99-109. PubMed ID: 9618150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenopus oocyte germinal-vesicle breakdown induced by [Val12]Ras is inhibited by a cytosol-localized Ras mutant.
    Gibbs JB; Schaber MD; Schofield TL; Scolnick EM; Sigal IS
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6630-4. PubMed ID: 2672000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two dominant inhibitory mutants of p21ras interfere with insulin-induced gene expression.
    Medema RH; Wubbolts R; Bos JL
    Mol Cell Biol; 1991 Dec; 11(12):5963-7. PubMed ID: 1658621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.